73 related articles for article (PubMed ID: 10701265)
21. High-throughput liquid chromatography/mass spectrometry method for the quantitation of small molecules using accurate mass technologies in supporting discovery drug screening.
Ding X; Ghobarah H; Zhang X; Jaochico A; Liu X; Deshmukh G; Liederer BM; Hop CE; Dean B
Rapid Commun Mass Spectrom; 2013 Feb; 27(3):401-8. PubMed ID: 23280971
[TBL] [Abstract][Full Text] [Related]
22. Metabolite characterization in drug discovery utilizing robotic liquid-handling, quadruple time-of-flight mass spectrometry and in-silico prediction.
Nassar AE; Adams PE
Curr Drug Metab; 2003 Aug; 4(4):259-71. PubMed ID: 12871044
[TBL] [Abstract][Full Text] [Related]
23. Quantification and rapid metabolite identification in drug discovery using API time-of-flight LC/MS.
Zhang N; Fountain ST; Bi H; Rossi DT
Anal Chem; 2000 Feb; 72(4):800-6. PubMed ID: 10701265
[TBL] [Abstract][Full Text] [Related]
24. Recent advances in metabolite identification and quantitative bioanalysis by LC-Q-TOF MS.
Xie C; Zhong D; Yu K; Chen X
Bioanalysis; 2012 May; 4(8):937-59. PubMed ID: 22533568
[TBL] [Abstract][Full Text] [Related]
25. An introduction to hybrid ion trap/time-of-flight mass spectrometry coupled with liquid chromatography applied to drug metabolism studies.
Liu ZY
J Mass Spectrom; 2012 Dec; 47(12):1627-42. PubMed ID: 23280752
[TBL] [Abstract][Full Text] [Related]
26. Critical practical aspects in the application of liquid chromatography-mass spectrometric studies for the characterization of impurities and degradation products.
Narayanam M; Handa T; Sharma P; Jhajra S; Muthe PK; Dappili PK; Shah RP; Singh S
J Pharm Biomed Anal; 2014 Jan; 87():191-217. PubMed ID: 23706957
[TBL] [Abstract][Full Text] [Related]
27. Role of liquid chromatography-high-resolution mass spectrometry (LC-HR/MS) in clinical toxicology.
Wu AH; Gerona R; Armenian P; French D; Petrie M; Lynch KL
Clin Toxicol (Phila); 2012 Sep; 50(8):733-42. PubMed ID: 22888997
[TBL] [Abstract][Full Text] [Related]
28. Liquid chromatography/atmospheric pressure ionization-mass spectrometry in drug metabolism studies.
Kostiainen R; Kotiaho T; Kuuranne T; Auriola S
J Mass Spectrom; 2003 Apr; 38(4):357-72. PubMed ID: 12717747
[TBL] [Abstract][Full Text] [Related]
29. High performance liquid chromatography/atmospheric pressure ionization/tandem mass spectrometry (HPLC/API/MS/MS) in drug metabolism and toxicology.
Kamel A; Prakash C
Curr Drug Metab; 2006 Dec; 7(8):837-52. PubMed ID: 17168686
[TBL] [Abstract][Full Text] [Related]
30. Recent development in liquid chromatography/mass spectrometry and emerging technologies for metabolite identification.
Liang Y; Wang G; Xie L; Sheng L
Curr Drug Metab; 2011 May; 12(4):329-44. PubMed ID: 21395529
[TBL] [Abstract][Full Text] [Related]
31. High-throughput quantitative bioanalysis by LC/MS/MS.
Jemal M
Biomed Chromatogr; 2000 Oct; 14(6):422-9. PubMed ID: 11002279
[TBL] [Abstract][Full Text] [Related]
32. Chiral liquid chromatography-tandem mass spectrometric methods for stereoisomeric pharmaceutical determinations.
Chen J; Korfmacher WA; Hsieh Y
J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Jun; 820(1):1-8. PubMed ID: 15866486
[TBL] [Abstract][Full Text] [Related]
33. Forced degradation and impurity profiling: recent trends in analytical perspectives.
Jain D; Basniwal PK
J Pharm Biomed Anal; 2013 Dec; 86():11-35. PubMed ID: 23969330
[TBL] [Abstract][Full Text] [Related]
34.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
35.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
36.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
